Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

The Pharmaceutical Journal

Timeline and infographic showing the development and safety of proton pump inhibitors

The development and safety of proton pump inhibitorsSubscription

By

Since the discovery of omeprazole in 1979, dispensing of proton pump inhibitors (PPIs) in England has increased more than 100-fold, and several products are now available without prescription. Although PPIs are effective and generally well tolerated, observational studies suggest an association with several adverse effects. Further trials are needed to establish causal relationships. 

See all our info graphics

Editorial

Balance with a single person on one side bringing up an entire group of people on the other, representing a lack of democracy

Do not blame RPS members for not voting in the board elections — give them something to vote forSubscription

The low number of members who voted in the RPS pharmacy board elections does not equate to apathy or despondency about pharmacy as a whole. 

Comment

A prism refracts white light into different colours, representing how disclosure of information leads towards transparency

How full disclosure of clinical trial data will benefit the pharmaceutical industrySubscription

By

Disclosing clinical trial data is a step in the right direction towards transparency, which benefits both the public and the pharmaceutical industry.

E-cigarette on top of a broken traditional cigarette

Pharmacists must retain healthy scepticism about e-cigarettesSubscription

By

Why e-cigarettes must not divert our focus from nicotine prevention and cessation.

Q&A

V Craig Jordan, the scientist who discovered the role of tamoxifen in breast cancer

Q&A: V Craig Jordan — the father of tamoxifenSubscription

By

V Craig Jordan, Dallas/Fort Worth living legend chair of cancer research, professor of both breast medical oncology and molecular and cellular oncology at the University of Texas MD Anderson Cancer Center in Houston, is best known as “the father of tamoxifen”.

Learning article

Anchin Pavilion (Florida, US) residents Helen Waldman and Jerry Osterweild experience Kobernick-Anchin-Benderson’s Multisensory and Reflections Program.

Dementia care: an overview of available non-pharmacological therapiesSubscription

By

A summary of non-pharmacological therapies for patients with dementia that may be used alongside licensed medicines.

Illustration showing possible errors in hospital and community scenarios

Understanding models of error and how they apply in clinical practiceSubscription

By ,

Models of human error can be helpful in determining why errors have occurred in the past, where future vulnerabilities may lie, and how healthcare professionals might take action to make clinical practice safer.

Careers

Graham Mould, pharmacist expert witness

What I do as a pharmacist expert witnessSubscription

By

Advising a solicitor about a drink driving case led Graham Mould to become a pharmacist expert witness.

Snapshot of Warman-Freed pharmacy during busy hours of the day

Structured training for community pharmacy staffSubscription

By

Finding the time and money to train pharmacists and pharmacy team members is not easy but there are business advantages of having well-trained staff, including a more knowledgeable and productive workforce.

Christine Rowlands, senior practitioner and clinical pathways lead with medicines management for the Health and Justice services

What I do as a pharmacist in the prison serviceSubscription

By

An interest in substance misuse led pharmacist Christine Rowlands to work in Health and Justice services.

News

Probuphine implant

FDA approves first buprenorphine implant for opioid dependence

The US Food and Drug Administration (FDA) has approved the first buprenorphine implant for the maintenance treatment of opioid dependence in adults, a treatment that is being hailed as “a game changer”.

Young boy with ADHD

Methylphenidate linked to increased risk of cardiovascular events in ADHD

The stimulant drug methylphenidate is associated with an increased risk of arrhythmias and myocardial infarction in children with attention deficit hyperactivity disorder (ADHD) during the early period of treatment, a study has found.

Zinbryta, the first one-monthly self-administered injection for MS

First self-administered monthly injection for multiple sclerosis approved in the US

Zinbryta (daclizumab), the first once-monthly self-administered injection for multiple sclerosis (MS), has been approved by the US Food and Drug Administration.

EMA approves combination treatment for type 2 diabetes

A new combination therapy that can lower blood glucose levels in patients with type 2 diabetes is being recommended for marketing approval for some patients by the European Medicines Agency (EMA).

Alastair Buxton, director of NHS services at the PSNC

PSNC, RPS and Pharmacy Voice to join forces and publish forward view for community pharmacy

Pharmacy bodies are working together to develop their own forward view as government rejects PSNC’s counterproposals to £170m cuts.

GSK headquarters, London

GSK announces initial findings from real world COPD study

Initial results have been announced from the Salford Lung Study, a phase III clinical trial in which researchers sought to discover how a new combination treatment for chronic obstructive pulmonary disease fared against traditional therapy in a real world setting.

News in Brief

Pharmacist holding a blister pack

RPS publishes updated guidance for prescribers of pharmaceutical specials Subscription

21 JUN 2016

The RPS has published updated professional guidance for the prescribers of pharmaceutical specials 

FDA issues warning over loperamide heart risks

15 JUN 2016

The US Food and Drug Administration (FDA) has issued a warning that high doses of the anti-diarrheal medication loperamide are associated with a risk of heart problems.

Raj Patel

UK pharmacist elected next president of Pharmaceutical Group of the European UnionSubscription

15 JUN 2016

A community pharmacist who owns a chain of high street pharmacies in the North West of England has been elected the next president of the Pharmaceutical Group of the European Union.

World Health Organization headquarters in Geneva

WHO guideline offers advice for when child-friendly medicines are unavailable

14 JUN 2016

The first-ever global guideline governing the prescribing and supply of children’s medicines when no authorised product exists has been developed by the World Health Organization and the International Pharmaceutical Federation.

NICE office logo

NICE scrutinises community pharmacy’s role in health promotionSubscription

14 JUN 2016

A consultation on the role and cost effectiveness of community pharmacy and its contribution to the promotion of health and wellbeing has been launched by the National Institute for Health and Care Excellence.

Sir Kevin Barron, chair of the APPG

All-Party Pharmacy Group calls for action on drug shortagesSubscription

10 JUN 2016

The All-Party Pharmacy Group has repeated its call for more to be done to tackle medicines shortages, after over half of community pharmacists responding to a survey said they dealt with drug shortages on a daily basis.

Duncan Rudkin, chief executive of the GPhC

Pharmacist prescribers say public and professionals do not understand roleSubscription

9 JUN 2016

Pharmacist prescribers say their skills and knowledge are underused because some health professionals and patients fail to understand what they can do, according to the results of a survey released by the General Pharmaceutical Council.

A student using a tablet

Centralised recruitment system for preregistration pharmacists to be introduced in EnglandSubscription

9 JUN 2016

A national centralised system that employers will use to recruit preregistration pharmacists is being introduced in England from 2017.

Health minister Alistair Burt

Government rethinks hub and spoke dispensing proposalsSubscription

8 JUN 2016

The government is to reconsider its plans for hub and spoke dispensing, according to health minister Alastair Burt.

The Pharmaceutical Journal

June 2016, Vol 295, No 7890

Cover Story:

More than 25 years after the gene for cystic fibrosis was discovered, there are signs that correcting this genetic deficit could soon be possible.

Read more…

The Pharmaceutical Journal

View previous issue

YOUR RPS

Pharmacist holding a blister pack

RPS publishes updated guidance for prescribers of pharmaceutical specials Subscription

The RPS has published updated professional guidance for the prescribers of pharmaceutical specials 

Aamer Safdar, member of the Royal Pharmaceutical Society (RPS) English Pharmacy Board

Pharmacists have a critical role to play in hospital emergency departmentsSubscription

By

Member of the RPS English Pharmacy Board, Aamer Safdar, makes the case for having pharmacists as a permanent fixture in hospital emergency departments. 

Announcements

For official announcements from The Royal Pharmaceutical society please visit the announcements page here.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.